Fortis Healthcare Q3 FY26: Revenue up 17.5% to ₹2,265 Cr, EBITDA surges 34.8%
Fortis Healthcare's Q3 FY26 consolidated revenue rose 17.5% YoY to ₹2,265 Cr. Operating EBITDA surged 34.8% to ₹505 Cr, with margins at 22.3%. The hospital business revenue grew 19.4% to ₹1,938 Cr. The company acquired People Tree Hospital for ₹430 Cr and launched a mental health facility.
Significant revenue and EBITDA growth, coupled with strategic acquisitions and business expansions, are material events that are likely to have a substantial impact on the company's financial performance and market position.
The company reported strong year-on-year growth in revenue and operating EBITDA for both consolidated and hospital businesses, along with improved margins. Strategic acquisitions and expansions also indicate positive business development.
Fortis Healthcare Limited announced its unaudited consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported a consolidated revenue of ₹2,265 crore for Q3 FY26, marking a 17.5% year-on-year increase. Operating EBITDA saw a significant jump of 34.8% to ₹505 crore, with the EBITDA margin improving to 22.3% from 19.4% in Q3 FY25.
The hospital business demonstrated strong performance with revenues growing by 19.4% to ₹1,938 crore, and operating EBITDA increasing by 28.9% to ₹420 crore, leading to an improved margin of 21.7% from 20.0% in the prior year's comparable quarter. Key growth drivers included a 14.3% increase in occupied beds and robust revenue from focus specialties.
Acquisitions and expansions were a key focus during the period. In January 2026, Fortis acquired the 125-bedded People Tree Hospital in Bengaluru for ₹430 crore. Additionally, the company launched ‘Adayu’, a 36-bedded specialized mental health care facility in Gurugram, in November 2025.
The diagnostics business reported gross revenues of ₹371 crore, an 8.3% increase year-on-year, with operating EBITDA margins improving to 23.1% from 14.4% in Q3 FY25. The company also saw an increase in its network of customer touch points to 4,370.
As of December 31, 2025, the company's net debt stood at ₹2,547 crore, with a Net Debt to EBITDA ratio of 1.24x. This increase in debt was primarily attributed to financing the acquisition of a stake in Agilus Diagnostics and the purchase of Shrimann Hospital.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.